Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;59(9):5798-803.
doi: 10.1128/AAC.01304-15. Epub 2015 Jul 13.

Inhibition of AAC(6')-Ib-mediated resistance to amikacin in Acinetobacter baumannii by an antisense peptide-conjugated 2',4'-bridged nucleic acid-NC-DNA hybrid oligomer

Affiliations

Inhibition of AAC(6')-Ib-mediated resistance to amikacin in Acinetobacter baumannii by an antisense peptide-conjugated 2',4'-bridged nucleic acid-NC-DNA hybrid oligomer

Christina Lopez et al. Antimicrob Agents Chemother. 2015 Sep.

Abstract

Multiresistant Acinetobacter baumannii, a common etiologic agent of severe nosocomial infections in compromised hosts, usually harbors aac(6')-Ib. This gene specifies resistance to amikacin and other aminoglycosides, seriously limiting the effectiveness of these antibiotics. An antisense oligodeoxynucleotide (ODN4) that binds to a duplicated sequence on the aac(6')-Ib mRNA, one of the copies overlapping the initiation codon, efficiently inhibited translation in vitro. An isosequential nuclease-resistant hybrid oligomer composed of 2',4'-bridged nucleic acid-NC (BNA(NC)) residues and deoxynucleotides (BNA(NC)-DNA) conjugated to the permeabilizing peptide (RXR)4XB ("X" and "B" stand for 6-aminohexanoic acid and β-alanine, respectively) (CPPBD4) inhibited translation in vitro at the same levels observed in testing ODN4. Furthermore, CPPBD4 in combination with amikacin inhibited growth of a clinical A. baumannii strain harboring aac(6')-Ib in liquid cultures, and when both compounds were used as combination therapy to treat infected Galleria mellonella organisms, survival was comparable to that seen with uninfected controls.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Chemical structure of a 2′,4′-BNANC residue.
FIG 2
FIG 2
Nucleotide sequences targeted by antisense ODNs. The nucleotide sequences around the initiation codon of the A. baumannii (Ab) A155 aac(6)-Ib gene are shown at the bottom of the figure. The duplicated sequences are within red and blue boxes. The sequences of the ODNs tested and the locations of antisense regions are shown at the top.
FIG 3
FIG 3
In vitro activities of ODNs. Cell-free translation reactions were carried out as described in Materials and Methods in the absence (−) or presence (+) of the indicated ODNs at 6.6 μM. The products were processed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the radioactivity was detected with a phosphorimager. A control lacking aac(6)-Ib mRNA was included (−). (A) “AS” stands for “antisense,” and the numbers indicate the ODN numbers corresponding to those shown in Fig. 2. “P” and “S” stand for ODNs antisense to a phoA sequence and sense sequence, respectively. (B) “AS” stands for “antisense.” “C4” and “CP” stand for “CPPBD4” and “CPPBDAP,” respectively.
FIG 4
FIG 4
Effect of CPPBD4 on resistance to AMK. A. baumannii A155 was cultured in 100 μl Mueller-Hinton broth in microtiter plates at 37°C, with the additions indicated in the figure, and the OD600 was determined every 20 min. CPPBD compounds were added at 0.5 μM and AMK at 4 μg/ml.
FIG 5
FIG 5
G. mellonella infection and treatment assays. Final-instar larva groups of 10 individuals were injected with the components shown in the figure, and a control group was not injected (“No injection”). The concentrations of the injected components were 10 mg AMK/kg of body weight and 0.5 μM CPPBD4 and CPPBDAP. The larvae were incubated at 37°C in the dark, and survival was recorded at 24-h intervals over 120 h.

Similar articles

Cited by

References

    1. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L. 2012. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One 7:e46984. doi:10.1371/journal.pone.0046984. - DOI - PMC - PubMed
    1. Hartstein AI, Rashad AL, Liebler JM, Actis LA, Freeman J, Rourke JW Jr, Stibolt TB, Tolmasky ME, Ellis GR, Crosa JH. 1988. Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and resuscitation bags. Am J Med 85:624–631. doi:10.1016/S0002-9343(88)80233-X. - DOI - PubMed
    1. Charnot-Katsikas A, Dorafshar AH, Aycock JK, David MZ, Weber SG, Frank KM. 2009. Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol 47:258–263. doi:10.1128/JCM.01250-08. - DOI - PMC - PubMed
    1. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471–3484. doi:10.1128/AAC.01464-06. - DOI - PMC - PubMed
    1. Bai H, You Y, Yan H, Meng J, Xue X, Hou Z, Zhou Y, Ma X, Sang G, Luo X. 2012. Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. Biomaterials 33:659–667. doi:10.1016/j.biomaterials.2011.09.075. - DOI - PubMed

Publication types

MeSH terms